Skip to main content

previous disabled Page of 2
and
  1. Article

    Eliciting requirements for a mammography training application

    PM Taylor, M Hartswood, L Blot, S Anderson, L Wilkinson in Breast Cancer Research (2008)

  2. Article

    Open Access

    Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold

    To evaluate current guidelines criteria for inclusion of women in special ‘breast cancer family history’ surveillance programmes, records were reviewed of women referred to Scottish breast cancer family clinic...

    E Anderson, J Berg, R Black, N Bradshaw, J Campbell in British Journal of Cancer (2008)

  3. Article

    Open Access

    Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer

    Cyclooxygenase-2 (COX-2) is associated with poor-prognosis breast cancer. We used a nude mouse xenograft model to determine the effects of COX-2 inhibition in breast cancer. Oestrogen receptor (ER)-positive MC...

    N L P Barnes, F Warnberg, G Farnie, D White, W Jiang in British Journal of Cancer (2007)

  4. Article

    Setting a lower risk threshold for surveillance within breast cancer family services

    R Black, A Fordyce, M Reis, D Goudie, L McLeish, H Carnaghan in Breast Cancer Research (2006)

  5. Article

    Open Access

    Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations

    There is considerable interest in whether anti-oestrogens can be used to prevent breast cancer in women bearing mutations in the BRCA1 and BRCA2 genes. The effects of oestradiol (E2), tamoxifen (TAM) and fulvestr...

    M Bramley, R B Clarke, A Howell, D G R Evans, T Armer in British Journal of Cancer (2006)

  6. Article

    Open Access

    Patient satisfaction with two different models of cancer genetic services in south-east Scotland

    There is a need to integrate primary- and secondary-care cancer genetic services, but the most appropriate model of service delivery remains unclear. This study reports patients’ expectations of breast cancer ...

    S Holloway, M Porteous, R Cetnarskyj, E Anderson, R Rush in British Journal of Cancer (2004)

  7. Article

    Open Access

    A randomised controlled trial of a psychoeducational intervention for women at increased risk of breast cancer

    This study aimed to compare the impact of two versions of a psychoeducational written intervention on cancer worry and objective knowledge of breast cancer risk-related topics in women who had been living with...

    S Appleton, M Watson, R Rush, S Garcia-Minaur, M Porteous in British Journal of Cancer (2004)

  8. Article

    Open Access

    Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland

    As part of a cluster randomised trial to assess an alternative model of cancer genetics services, we gathered data on all referrals from general practitioners (GPs) to cancer genetics services in South East Sc...

    H Campbell, S Holloway, R Cetnarskyj, E Anderson, R Rush in British Journal of Cancer (2003)

  9. Article

    Regulation of human mammary stem cells

    RB Clarke, E Anderson, A Howell, H Okano, CS Potten in Breast Cancer Research (2003)

  10. Article

    Open Access

    A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact

    This study compared the psychological impact of two models of breast cancer genetics services in South East Scotland. One hundred and seventy general practices were randomised to refer patients to the existing...

    A Fry, A Cull, S Appleton, R Rush, S Holloway, D Gorman in British Journal of Cancer (2003)

  11. Article

    Open Access

    Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells

    The reverse transcriptase polymerase chain reaction (RT-PCR) is a sensitive technique that can detect prostate-specific messenger RNA in circulating blood. Many authors have studied the potential of RT-PCR as ...

    I G McIntyre, K Spreckley, R B Clarke, E Anderson, N W Clarke in British Journal of Cancer (2000)

  12. No Access

    Chapter and Conference Paper

    The Primary Use of Endocrine Therapies

    The major objective of nearly all studies of primary endocrine therapy has been to assess whether surgery can be deferred indefinitely without impairing survival, particularly in elderly infirm patients (Preec...

    A. Howell, E. Anderson, R. Blamey in Adjuvant Therapy of Primary Breast Cancer … (1998)

  13. No Access

    Article

    Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone

    The epithelial proliferation of normal human breast tissue xenografts implanted into athymic nude mice is significantly increased from basal levels by oestradiol (E2), but not progesterone (Pg) treatment at se...

    RB Clarke, A Howell, E Anderson in British Journal of Cancer (1997)

  14. No Access

    Article

    High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study

    Current treatments for metastatic breast cancer are not associated with significant survival benefits despite response rates of over 50%. High-dose therapy with autologous bone marrow transplantation (ABMT) ha...

    DA Cameron, J Craig, H Gabra, L Lee, J MacKay, AC Parker in British Journal of Cancer (1996)

  15. No Access

    Article

    Transforming growth factor β 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients

    Members of the transforming growth factor beta (TGF-beta family, in particular TGF-beta 1, are some of the most potent inhibitory growth factors in a variety of cell types. Resistance to TGF-beta 1-induced gro...

    H Robson, E Anderson, RD James, PF Schofield in British Journal of Cancer (1996)

  16. No Access

    Article

    Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

    We have assessed the pharmacokinetics, pharmacological and anti-tumour effects of the specific steroidal anti-oestrogen ICI 182780 in 19 patients with advanced breast cancer resistant to tamoxifen. The agent w...

    A Howell, DJ DeFriend, JFR Robertson, RW Blamey, L Anderson in British Journal of Cancer (1996)

  17. No Access

    Article

    Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas

    Evidence of accumulating for the failure of apoptosis as an important factor in the evolution of colorectal cancer and its poor response to adjuvant therapy. The proto-oncogene bcl-2 suppresses apoptosis. Its ...

    AJM Watson, AJ Merritt, LS Jones, JN Askew, E Anderson in British Journal of Cancer (1996)

  18. No Access

    Article

    Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro

    We have investigated the effects on breast cancer cell growth of 4-hydroxytamoxifen (4OHT), a conventional antioestrogen with agonist activity, and 7 alpha-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra...

    DJ DeFriend, E Anderson, J Bell, DP Wilks, CML West, RE Mansel in British Journal of Cancer (1994)

  19. No Access

    Article

    Expression of activated gelatinase in human invasive breast carcinoma

    The expression of both 92- and 72-kDa gelatinases has been studied in 20 samples of human breast carcinoma by the technique of gelatin zymography. This technique allowed the relative amount of each gelatinase ...

    P. D. Brown, R. E. Bloxidge, E. Anderson, A. Howell in Clinical & Experimental Metastasis (1993)

  20. No Access

    Article

    Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status

    This study aimed to investigate the effect of tamoxifen on breast tumour levels of oestrogen and progesterone receptor (ER and PR) and proliferation as defined by the Ki67 antibody. A group of primary breast c...

    RB Clarke, IJ Laidlaw, LJ Jones, A Howell, E Anderson in British Journal of Cancer (1993)

previous disabled Page of 2